Stock CE CELANESE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
154.5 USD +0.85% Intraday chart for Celanese Corporation +0.03% -0.57%
Apr. 22 Celanese Corporation Announces Directorate Changes CI
Apr. 19 RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,882 15,189 18,297 11,086 16,913 17,235 - -
Enterprise Value (EV) 1 18,324 17,957 21,728 24,257 28,792 27,864 26,409 25,140
P/E ratio 18 x 7.76 x 9.97 x 5.9 x 8.67 x 14.1 x 11.2 x 11.6 x
Yield 1.95% 1.91% 1.62% 2.68% 1.8% 1.82% 1.88% 2.02%
Capitalization / Revenue 2.36 x 2.69 x 2.14 x 1.15 x 1.55 x 1.55 x 1.46 x 1.4 x
EV / Revenue 2.91 x 3.18 x 2.55 x 2.51 x 2.63 x 2.5 x 2.24 x 2.04 x
EV / EBITDA 10.2 x 12.2 x 7.66 x 9.27 x 11.8 x 10.3 x 8.78 x 8.08 x
EV / FCF 16.9 x 18.3 x 16.8 x 19 x 21.8 x 18.7 x 17.3 x 14.3 x
FCF Yield 5.92% 5.45% 5.94% 5.26% 4.58% 5.36% 5.78% 6.97%
Price to Book 5.91 x 4.34 x 4.33 x 1.97 x 2.4 x 2.1 x 1.85 x 1.63 x
Nbr of stocks (in thousands) 120,874 116,895 108,871 108,428 108,855 111,563 - -
Reference price 2 123.1 129.9 168.1 102.2 155.4 154.5 154.5 154.5
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,297 5,655 8,537 9,673 10,940 11,146 11,775 12,350
EBITDA 1 1,805 1,475 2,835 2,617 2,444 2,717 3,009 3,110
EBIT 1 1,476 1,131 2,473 2,171 1,753 1,976 2,249 2,450
Operating Margin 23.44% 20% 28.97% 22.44% 16.02% 17.72% 19.1% 19.84%
Earnings before Tax (EBT) 1 988 2,251 2,248 1,421 1,183 1,379 1,769 1,807
Net income 1 852 1,985 1,890 1,894 1,960 1,191 1,492 1,467
Net margin 13.53% 35.1% 22.14% 19.58% 17.92% 10.68% 12.67% 11.88%
EPS 2 6.840 16.75 16.86 17.34 17.92 10.98 13.76 13.33
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,494 1,527 1,753
FCF margin 17.21% 17.31% 15.11% 13.19% 12.07% 13.4% 12.97% 14.2%
FCF Conversion (EBITDA) 60.06% 66.37% 45.5% 48.76% 54.01% 54.97% 50.76% 56.39%
FCF Conversion (Net income) 127.23% 49.32% 68.25% 67.37% 67.35% 125.44% 102.38% 119.54%
Dividend per Share 2 2.400 2.480 2.720 2.740 2.800 2.812 2.910 3.118
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,266 2,275 2,538 2,486 2,301 2,348 2,853 2,795 2,723 2,569 2,684 2,836 2,852 2,721 2,851
EBITDA 1 739 745 813 744 607 453 596 616 624 608 574.7 693.8 741.5 707.4 714.2
EBIT 1 648 652 713 646 510 302 424 444 451 434 394.5 510.4 553.8 522.4 553.6
Operating Margin 28.6% 28.66% 28.09% 25.99% 22.16% 12.86% 14.86% 15.89% 16.56% 16.89% 14.7% 18% 19.42% 19.2% 19.42%
Earnings before Tax (EBT) 1 622 557 616 554 321 -70 121 216 714 132 226.3 354 410.3 388.3 392.5
Net income 1 506 524 502 434 191 767 91 219 951 698 202 311 360.2 338.2 351.5
Net margin 22.33% 23.03% 19.78% 17.46% 8.3% 32.67% 3.19% 7.84% 34.92% 27.17% 7.53% 10.97% 12.63% 12.43% 12.33%
EPS 2 4.560 4.790 4.610 3.980 1.750 7.030 0.8300 2.000 8.690 6.370 1.851 2.861 3.342 3.158 3.220
Dividend per Share 2 0.6800 0.6800 0.6800 0.6800 0.6800 0.7000 0.7000 0.7000 - 0.7000 0.6967 0.7000 0.7083 0.7200 0.7167
Announcement Date 10/21/21 1/27/22 4/28/22 7/28/22 11/3/22 2/23/23 5/9/23 8/7/23 11/6/23 2/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,442 2,768 3,431 13,171 11,879 10,629 9,174 7,904
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.907 x 1.877 x 1.21 x 5.033 x 4.86 x 3.912 x 3.049 x 2.542 x
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,494 1,527 1,753
ROE (net income / shareholders' equity) 43.3% 30% 52.7% 35.3% 15.3% 16.5% 17.9% 17.6%
ROA (Net income/ Total Assets) 9.07% 19.5% 16.5% 9.07% 3.69% 4.61% 5.61% 6.17%
Assets 1 9,395 10,193 11,442 20,888 53,086 25,810 26,590 23,767
Book Value Per Share 2 20.80 29.90 38.80 52.00 64.80 73.60 83.40 94.70
Cash Flow per Share 2 11.70 11.30 15.70 16.70 17.40 16.90 19.10 21.80
Capex 1 370 364 467 543 568 427 493 529
Capex / Sales 5.88% 6.44% 5.47% 5.61% 5.19% 3.83% 4.18% 4.28%
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Celanese Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
154.5 USD
Average target price
162 USD
Spread / Average Target
+4.86%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+35.12% 12.81B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. CE Stock
  4. Financials Celanese Corporation